[
    {
        "text": "(soft music)",
        "start": 0.324,
        "duration": 2.417
    },
    {
        "text": "It's my real honor",
        "start": 8.858,
        "duration": 1.562
    },
    {
        "text": "to be part of this year's Talent Twelve program.",
        "start": 10.42,
        "duration": 2.596
    },
    {
        "text": "And for me, it has been two very exciting days",
        "start": 13.016,
        "duration": 3.114
    },
    {
        "text": "to hear these inspiring stories from our keynote speakers",
        "start": 16.13,
        "duration": 3.88
    },
    {
        "text": "and my fellow scientists, and I say thank you to you all.",
        "start": 20.01,
        "duration": 3.35
    },
    {
        "text": "And I wanna say a special thank you to ACS and C&EN News",
        "start": 23.36,
        "duration": 5.0
    },
    {
        "text": "for bringing together this fantastic symposium.",
        "start": 28.4,
        "duration": 2.71
    },
    {
        "text": "Now, my name is Ziyang Zhang,",
        "start": 31.11,
        "duration": 1.58
    },
    {
        "text": "I am a postdoc in Kevan Shokat Lab at UCSF.",
        "start": 32.69,
        "duration": 4.61
    },
    {
        "text": "I'm a student of chemistry.",
        "start": 37.3,
        "duration": 2.38
    },
    {
        "text": "And for me chemistry is the most exciting",
        "start": 39.68,
        "duration": 1.85
    },
    {
        "text": "when I can use it as a lens",
        "start": 41.53,
        "duration": 2.2
    },
    {
        "text": "to better understand human diseases",
        "start": 43.73,
        "duration": 2.25
    },
    {
        "text": "and as a tool to find better treatments.",
        "start": 45.98,
        "duration": 2.513
    },
    {
        "text": "And in my research,",
        "start": 50.18,
        "duration": 1.25
    },
    {
        "text": "I would always start by asking one simple question,",
        "start": 51.43,
        "duration": 3.91
    },
    {
        "text": "which is what is the chemical difference",
        "start": 55.34,
        "duration": 2.69
    },
    {
        "text": "between an healthy state and a diseased state.",
        "start": 58.03,
        "duration": 3.61
    },
    {
        "text": "Now, for example, in a bacterial infection,",
        "start": 61.64,
        "duration": 2.23
    },
    {
        "text": "we have two completely different species.",
        "start": 63.87,
        "duration": 2.63
    },
    {
        "text": "And these different species, the bacteria,",
        "start": 66.5,
        "duration": 3.23
    },
    {
        "text": "are causing the disease.",
        "start": 69.73,
        "duration": 1.71
    },
    {
        "text": "So we can target this difference",
        "start": 71.44,
        "duration": 3.59
    },
    {
        "text": "and exploit the vulnerability of the bacterial ribosome.",
        "start": 75.03,
        "duration": 3.89
    },
    {
        "text": "Now, but we don't always have two different species",
        "start": 78.92,
        "duration": 3.1
    },
    {
        "text": "to work with in human diseases.",
        "start": 82.02,
        "duration": 1.86
    },
    {
        "text": "Sometimes, our disease may be localized",
        "start": 83.88,
        "duration": 3.23
    },
    {
        "text": "in a certain tissue of the body,",
        "start": 87.11,
        "duration": 1.86
    },
    {
        "text": "but not other parts, such as a brain.",
        "start": 88.97,
        "duration": 2.193
    },
    {
        "text": "But in some extreme cases,",
        "start": 92.26,
        "duration": 1.77
    },
    {
        "text": "our chemical difference could be as subtle",
        "start": 94.03,
        "duration": 3.02
    },
    {
        "text": "as a single amino acid change on a single oncoprotein,",
        "start": 97.05,
        "duration": 4.66
    },
    {
        "text": "between cancer cells and the normal cells.",
        "start": 101.71,
        "duration": 2.553
    },
    {
        "text": "Now today, I wanna spend the next few minutes",
        "start": 105.12,
        "duration": 3.33
    },
    {
        "text": "to tell you about a chemical trick we developed,",
        "start": 108.45,
        "duration": 3.32
    },
    {
        "text": "which allowed us to navigate a drug",
        "start": 111.77,
        "duration": 2.74
    },
    {
        "text": "specifically to the brain,",
        "start": 114.51,
        "duration": 1.37
    },
    {
        "text": "to treat central nervous system diseases.",
        "start": 115.88,
        "duration": 2.193
    },
    {
        "text": "Now, I'm sure many of you know,",
        "start": 120.15,
        "duration": 2.02
    },
    {
        "text": "brain diseases can be very difficult to treat,",
        "start": 122.17,
        "duration": 2.408
    },
    {
        "text": "because of the unique function and anatomy of our brain.",
        "start": 124.578,
        "duration": 5.0
    },
    {
        "text": "Now for example, this disease, glioblastoma,",
        "start": 129.94,
        "duration": 3.42
    },
    {
        "text": "is the most aggressive type of brain cancer,",
        "start": 133.36,
        "duration": 2.6
    },
    {
        "text": "which affects tens of thousands of patients every year",
        "start": 135.96,
        "duration": 3.66
    },
    {
        "text": "across the world.",
        "start": 139.62,
        "duration": 1.53
    },
    {
        "text": "We don't have targeted molecular therapy for glioblastoma,",
        "start": 141.15,
        "duration": 3.49
    },
    {
        "text": "and our current options",
        "start": 144.64,
        "duration": 1.4
    },
    {
        "text": "are only limited to chemotherapy and radiotherapy.",
        "start": 146.04,
        "duration": 3.073
    },
    {
        "text": "Now what's fortunate is that",
        "start": 150.14,
        "duration": 1.9
    },
    {
        "text": "recent research has shown that these tumor cells",
        "start": 152.04,
        "duration": 2.54
    },
    {
        "text": "are very dependent on a particular signaling pathway",
        "start": 154.58,
        "duration": 4.23
    },
    {
        "text": "called the mTOR pathway.",
        "start": 158.81,
        "duration": 2.04
    },
    {
        "text": "So it would make sense that",
        "start": 160.85,
        "duration": 1.9
    },
    {
        "text": "one can find a drug to target this vulnerability",
        "start": 162.75,
        "duration": 3.28
    },
    {
        "text": "and to stop the tumor cells from growing.",
        "start": 166.03,
        "duration": 2.73
    },
    {
        "text": "And that is exactly true.",
        "start": 168.76,
        "duration": 2.46
    },
    {
        "text": "In fact, this molecule called RapaLink-1,",
        "start": 171.22,
        "duration": 2.87
    },
    {
        "text": "slightly scary looking as a chemical,",
        "start": 174.09,
        "duration": 2.34
    },
    {
        "text": "but it is a very good inhibitor of the mTOR protein.",
        "start": 176.43,
        "duration": 4.7
    },
    {
        "text": "And so you might think that this is gonna work,",
        "start": 181.13,
        "duration": 4.02
    },
    {
        "text": "and in fact it does.",
        "start": 185.15,
        "duration": 1.56
    },
    {
        "text": "In animal models, this RapaLink-1 molecule",
        "start": 186.71,
        "duration": 2.92
    },
    {
        "text": "can reverse the tumor growth and constitute regress,",
        "start": 189.63,
        "duration": 3.95
    },
    {
        "text": "and greatly extend the lifespan",
        "start": 193.58,
        "duration": 2.38
    },
    {
        "text": "of the mice bearing these tumors.",
        "start": 195.96,
        "duration": 1.773
    },
    {
        "text": "So we're almost there,",
        "start": 198.73,
        "duration": 1.68
    },
    {
        "text": "we're almost thinking that we have found a solution,",
        "start": 200.41,
        "duration": 2.95
    },
    {
        "text": "except that our potential solution has one problem,",
        "start": 203.36,
        "duration": 4.04
    },
    {
        "text": "and the problem has to do with the drug,",
        "start": 207.4,
        "duration": 2.23
    },
    {
        "text": "with where the drug actually goes.",
        "start": 209.63,
        "duration": 1.863
    },
    {
        "text": "Now, if the drug goes through the brain,",
        "start": 212.39,
        "duration": 2.21
    },
    {
        "text": "it can fight the tumor there",
        "start": 214.6,
        "duration": 1.41
    },
    {
        "text": "by inhibiting the mTOR and tumor tissues,",
        "start": 216.01,
        "duration": 2.33
    },
    {
        "text": "but part of the drug,",
        "start": 218.34,
        "duration": 1.5
    },
    {
        "text": "and in fact the majority of the drug will end up",
        "start": 219.84,
        "duration": 2.36
    },
    {
        "text": "in other tissues of the body.",
        "start": 222.2,
        "duration": 2.24
    },
    {
        "text": "And there the drug doesn't have a tumor to fight.",
        "start": 224.44,
        "duration": 2.3
    },
    {
        "text": "So, in fact, it will inhibit the mTOR of our normal cells",
        "start": 226.74,
        "duration": 4.7
    },
    {
        "text": "and cause unacceptable toxic effects.",
        "start": 231.44,
        "duration": 2.43
    },
    {
        "text": "And the reason why, is because of what mTOR is (indistinct)",
        "start": 233.87,
        "duration": 5.0
    },
    {
        "text": "it turns out to be a central controller of the cell,",
        "start": 241.45,
        "duration": 3.5
    },
    {
        "text": "and I wanna say thank you to Shany,",
        "start": 244.95,
        "duration": 2.13
    },
    {
        "text": "for giving a wonderful introduction to protein kinases,",
        "start": 247.08,
        "duration": 3.8
    },
    {
        "text": "mTOR is protein kinase too.",
        "start": 250.88,
        "duration": 3.34
    },
    {
        "text": "And what it does is that it integrates a bunch of signals",
        "start": 254.22,
        "duration": 4.31
    },
    {
        "text": "that including nutrients and stress,",
        "start": 258.53,
        "duration": 3.27
    },
    {
        "text": "and it turns these signals into instructions for the cell,",
        "start": 261.8,
        "duration": 3.82
    },
    {
        "text": "when and how to grow.",
        "start": 265.62,
        "duration": 1.42
    },
    {
        "text": "And these instructions take the form",
        "start": 267.04,
        "duration": 1.91
    },
    {
        "text": "of protein phosphorylation,",
        "start": 268.95,
        "duration": 1.543
    },
    {
        "text": "is a function of a protein kinase.",
        "start": 271.639,
        "duration": 1.7
    },
    {
        "text": "But what we really want to do, is actually find a drug",
        "start": 275.653,
        "duration": 2.347
    },
    {
        "text": "that can navigate itself to the brain,",
        "start": 278.0,
        "duration": 2.69
    },
    {
        "text": "but doesn't go where it doesn't need to go.",
        "start": 280.69,
        "duration": 2.63
    },
    {
        "text": "But, how can we do that?",
        "start": 283.32,
        "duration": 1.68
    },
    {
        "text": "Well,",
        "start": 285.0,
        "duration": 0.833
    },
    {
        "text": "in the next two minutes I'm just gonna show you,",
        "start": 287.63,
        "duration": 1.78
    },
    {
        "text": "we found a two drug strategy, where we use a second molecule",
        "start": 289.41,
        "duration": 3.76
    },
    {
        "text": "to control where the first molecule goes and where it works.",
        "start": 293.17,
        "duration": 4.86
    },
    {
        "text": "And to show you how this works,",
        "start": 298.03,
        "duration": 2.06
    },
    {
        "text": "we need to take a more serious look at our drug,",
        "start": 300.09,
        "duration": 3.28
    },
    {
        "text": "which is a gimongous molecule,",
        "start": 303.37,
        "duration": 1.63
    },
    {
        "text": "and our protein, which is a gimongous protein.",
        "start": 305.0,
        "duration": 2.86
    },
    {
        "text": "Now, this RapaLink-1 molecule is a derivative",
        "start": 307.86,
        "duration": 3.45
    },
    {
        "text": "of natural product called rapamycin,",
        "start": 311.31,
        "duration": 3.01
    },
    {
        "text": "and as many of you know,",
        "start": 314.32,
        "duration": 1.73
    },
    {
        "text": "rapamycin has its own page in the history",
        "start": 316.05,
        "duration": 2.77
    },
    {
        "text": "of chemical biology.",
        "start": 318.82,
        "duration": 1.66
    },
    {
        "text": "And it's so special because of the way it works.",
        "start": 320.48,
        "duration": 3.37
    },
    {
        "text": "Unlike normal small molecules that just finds its target,",
        "start": 323.85,
        "duration": 3.46
    },
    {
        "text": "rapamycin actually finds help from a irrelevant protein,",
        "start": 327.31,
        "duration": 5.0
    },
    {
        "text": "and acts as a molecule of glue to stitch",
        "start": 332.5,
        "duration": 3.43
    },
    {
        "text": "mTOR to this irrelevant protein called FKBP12.",
        "start": 335.93,
        "duration": 3.88
    },
    {
        "text": "Now as a result, you have a protein sandwich here,",
        "start": 339.81,
        "duration": 3.13
    },
    {
        "text": "and this innocent FKBP12",
        "start": 342.94,
        "duration": 2.77
    },
    {
        "text": "actually blocks mTOR from doing its normal job.",
        "start": 345.71,
        "duration": 3.34
    },
    {
        "text": "So in cell, what our molecule does,",
        "start": 349.05,
        "duration": 2.11
    },
    {
        "text": "is that it will first go find this FKBP12 protein,",
        "start": 351.16,
        "duration": 3.663
    },
    {
        "text": "and say, hey, I need your help to do something.",
        "start": 356.18,
        "duration": 2.49
    },
    {
        "text": "And these two then go hand in hand",
        "start": 358.67,
        "duration": 2.67
    },
    {
        "text": "to find our mTOR target,",
        "start": 361.34,
        "duration": 2.23
    },
    {
        "text": "to engage it in a high affinity by (indistinct) interaction.",
        "start": 363.57,
        "duration": 3.633
    },
    {
        "text": "So it's all too complicated,",
        "start": 368.1,
        "duration": 1.56
    },
    {
        "text": "but suffice to say, what is going on here",
        "start": 369.66,
        "duration": 3.65
    },
    {
        "text": "is that our molecule absolutely needs its FKBP friend",
        "start": 373.31,
        "duration": 5.0
    },
    {
        "text": "to do its work.",
        "start": 378.52,
        "duration": 1.213
    },
    {
        "text": "So without FKBP molecule, I will not inhibit mTOR at all.",
        "start": 380.61,
        "duration": 4.21
    },
    {
        "text": "Now, with this knowledge,",
        "start": 384.82,
        "duration": 1.68
    },
    {
        "text": "we suddenly think back and looked at our original problem.",
        "start": 386.5,
        "duration": 5.0
    },
    {
        "text": "The problem is that we have our drug molecule everywhere",
        "start": 392.0,
        "duration": 2.89
    },
    {
        "text": "and inhibiting mTOR everywhere is bad.",
        "start": 394.89,
        "duration": 2.94
    },
    {
        "text": "So we thought, well,",
        "start": 397.83,
        "duration": 1.81
    },
    {
        "text": "if we could find a random molecule to steal FKBP away",
        "start": 399.64,
        "duration": 4.537
    },
    {
        "text": "from our green active inhibitor,",
        "start": 405.41,
        "duration": 3.37
    },
    {
        "text": "we can stop it from wreaking havoc outside the brain,",
        "start": 408.78,
        "duration": 4.25
    },
    {
        "text": "and if we put a condition,",
        "start": 413.03,
        "duration": 1.74
    },
    {
        "text": "that is, red molecule doesn't get into the brain,",
        "start": 414.77,
        "duration": 2.67
    },
    {
        "text": "we can actually solve this problem",
        "start": 417.44,
        "duration": 1.7
    },
    {
        "text": "by controlling when this, our inhibitor works.",
        "start": 420.14,
        "duration": 4.47
    },
    {
        "text": "So to you find this red molecule,",
        "start": 424.61,
        "duration": 2.607
    },
    {
        "text": "we started looking at this problem for chemical lens.",
        "start": 427.217,
        "duration": 3.886
    },
    {
        "text": "What we really want to do",
        "start": 432.836,
        "duration": 2.104
    },
    {
        "text": "is to find both that doesn't get into the brain.",
        "start": 434.94,
        "duration": 3.25
    },
    {
        "text": "So we took on this challenge by chemically modifying",
        "start": 438.19,
        "duration": 3.73
    },
    {
        "text": "two existing ligands of FKBP12,",
        "start": 441.92,
        "duration": 2.92
    },
    {
        "text": "and we can actually learn from decades",
        "start": 444.84,
        "duration": 3.57
    },
    {
        "text": "of drug discovery efforts,",
        "start": 448.41,
        "duration": 1.52
    },
    {
        "text": "in central nervous system diseases,",
        "start": 449.93,
        "duration": 2.551
    },
    {
        "text": "and normally, people want to find a drug",
        "start": 452.481,
        "duration": 3.859
    },
    {
        "text": "that gets into the brain.",
        "start": 456.34,
        "duration": 2.44
    },
    {
        "text": "But here, we're gonna do the exact opposite",
        "start": 458.78,
        "duration": 2.29
    },
    {
        "text": "of what people normally wanna do.",
        "start": 461.07,
        "duration": 1.82
    },
    {
        "text": "We're gonna put polar functional groups onto these molecules",
        "start": 462.89,
        "duration": 3.11
    },
    {
        "text": "so that they don't get into the brain.",
        "start": 466.0,
        "duration": 1.9
    },
    {
        "text": "And a long story short, we identified one such molecule,",
        "start": 468.8,
        "duration": 4.26
    },
    {
        "text": "which we call RapaBlock,",
        "start": 473.06,
        "duration": 2.27
    },
    {
        "text": "and we tested whether they can actually help us achieve",
        "start": 475.33,
        "duration": 4.33
    },
    {
        "text": "for a specific inhibition.",
        "start": 479.66,
        "duration": 1.41
    },
    {
        "text": "So we treated mice with a singled mTOR inhibitor",
        "start": 481.07,
        "duration": 4.2
    },
    {
        "text": "for a combination of these two,",
        "start": 485.27,
        "duration": 2.11
    },
    {
        "text": "and we looked at how they affect mTOR signaling",
        "start": 487.38,
        "duration": 3.36
    },
    {
        "text": "in different tissues.",
        "start": 490.74,
        "duration": 1.94
    },
    {
        "text": "If we look at the muscle tissue,",
        "start": 492.68,
        "duration": 1.25
    },
    {
        "text": "we see that our RapaLink-1 molecule itself",
        "start": 493.93,
        "duration": 3.8
    },
    {
        "text": "wiped out the phosphorylation signals here,",
        "start": 497.73,
        "duration": 2.96
    },
    {
        "text": "indicating that mTOR is being inhibited",
        "start": 500.69,
        "duration": 2.03
    },
    {
        "text": "by a single molecule.",
        "start": 502.72,
        "duration": 2.11
    },
    {
        "text": "But if we use these two molecules together,",
        "start": 504.83,
        "duration": 3.81
    },
    {
        "text": "we don't see this effect.",
        "start": 508.64,
        "duration": 2.11
    },
    {
        "text": "On the other hand, if we look at the brain tissue,",
        "start": 510.75,
        "duration": 2.09
    },
    {
        "text": "we'll see that mTOR was inhibited in both of them,",
        "start": 512.84,
        "duration": 4.96
    },
    {
        "text": "either when mice is treated with a single inhibitor,",
        "start": 517.8,
        "duration": 3.64
    },
    {
        "text": "or a combination of these two molecules.",
        "start": 521.44,
        "duration": 1.96
    },
    {
        "text": "So what this tell us is that,",
        "start": 523.4,
        "duration": 2.63
    },
    {
        "text": "we are able to actually achieve brain inhibition,",
        "start": 526.03,
        "duration": 4.1
    },
    {
        "text": "sorry, inhibition of mTOR in the brain",
        "start": 530.13,
        "duration": 1.91
    },
    {
        "text": "without affecting it in the muscle (indistinct) therapy.",
        "start": 532.04,
        "duration": 3.413
    },
    {
        "text": "Now, what does it do?",
        "start": 536.69,
        "duration": 1.96
    },
    {
        "text": "Well, we can show that our combination therapy",
        "start": 538.65,
        "duration": 2.98
    },
    {
        "text": "mitigates typical toxic side effects",
        "start": 541.63,
        "duration": 2.14
    },
    {
        "text": "we see with mTOR inhibitors, such as body weight loss,",
        "start": 543.77,
        "duration": 2.86
    },
    {
        "text": "and intolerance to blood glucose.",
        "start": 546.63,
        "duration": 2.423
    },
    {
        "text": "And, but on the other hand,",
        "start": 550.72,
        "duration": 2.25
    },
    {
        "text": "our combination therapy is as effective",
        "start": 552.97,
        "duration": 3.285
    },
    {
        "text": "as inhibiting tumor growth",
        "start": 556.255,
        "duration": 1.985
    },
    {
        "text": "and extending the survival of tumor bearing mice.",
        "start": 558.24,
        "duration": 4.613
    },
    {
        "text": "So to summarize, we started with a problem,",
        "start": 564.22,
        "duration": 2.28
    },
    {
        "text": "which is how can we treat a tumor in the brain?",
        "start": 566.5,
        "duration": 3.04
    },
    {
        "text": "And the solution, the potential solution",
        "start": 569.54,
        "duration": 2.69
    },
    {
        "text": "was to target the vulnerability of these tumor cells",
        "start": 572.23,
        "duration": 3.16
    },
    {
        "text": "to stop them from growth.",
        "start": 575.39,
        "duration": 2.02
    },
    {
        "text": "But we had a second problem",
        "start": 577.41,
        "duration": 1.385
    },
    {
        "text": "because inhibiting mTOR everywhere is bad.",
        "start": 578.795,
        "duration": 4.515
    },
    {
        "text": "So we decided to take a chemical approach",
        "start": 583.31,
        "duration": 3.79
    },
    {
        "text": "and develop the trick",
        "start": 587.1,
        "duration": 1.27
    },
    {
        "text": "where we use a second molecule to control",
        "start": 588.37,
        "duration": 2.28
    },
    {
        "text": "when the first molecule is going to work.",
        "start": 590.65,
        "duration": 2.283
    },
    {
        "text": "And in doing so, we can achieve selective targeting",
        "start": 592.933,
        "duration": 3.997
    },
    {
        "text": "of brain tissues.",
        "start": 596.93,
        "duration": 1.71
    },
    {
        "text": "Now, although I only talked about brain tumors today,",
        "start": 598.64,
        "duration": 2.83
    },
    {
        "text": "we have used our approach",
        "start": 601.47,
        "duration": 1.62
    },
    {
        "text": "in other central nervous system diseases,",
        "start": 603.09,
        "duration": 1.96
    },
    {
        "text": "such as alcohol use disorder and Parkinson's disease.",
        "start": 605.05,
        "duration": 2.913
    },
    {
        "text": "And we think that this general idea",
        "start": 610.58,
        "duration": 2.44
    },
    {
        "text": "of helping a drug go exactly where it needs to go,",
        "start": 613.02,
        "duration": 4.33
    },
    {
        "text": "has a great potential to help us find more safer",
        "start": 617.35,
        "duration": 3.33
    },
    {
        "text": "and more effective therapeutics.",
        "start": 620.68,
        "duration": 1.883
    },
    {
        "text": "Now, I really have numerous people to thank",
        "start": 624.45,
        "duration": 2.91
    },
    {
        "text": "on my chemistry journey,",
        "start": 627.36,
        "duration": 1.28
    },
    {
        "text": "and I'm very privileged to have had great mentors,",
        "start": 628.64,
        "duration": 2.8
    },
    {
        "text": "colleagues, friends, dear family with me along my way,",
        "start": 631.44,
        "duration": 3.26
    },
    {
        "text": "and there's definitely no way I could have made it this far",
        "start": 634.7,
        "duration": 2.22
    },
    {
        "text": "without their support.",
        "start": 636.92,
        "duration": 1.3
    },
    {
        "text": "But for the research I presented today,",
        "start": 638.22,
        "duration": 2.29
    },
    {
        "text": "I wanna specifically thank",
        "start": 640.51,
        "duration": 1.67
    },
    {
        "text": "my postdoc supervisors Kevan Shokat,",
        "start": 642.18,
        "duration": 2.3
    },
    {
        "text": "for showing me what chemistry can really do,",
        "start": 644.48,
        "duration": 4.27
    },
    {
        "text": "it can make a difference to the health of the people",
        "start": 648.75,
        "duration": 4.38
    },
    {
        "text": "and well being a society.",
        "start": 653.13,
        "duration": 1.84
    },
    {
        "text": "I wanna thank my co-workers, Kevin and Doug,",
        "start": 654.97,
        "duration": 3.11
    },
    {
        "text": "for joining me to tackle this difficult problem.",
        "start": 658.08,
        "duration": 3.45
    },
    {
        "text": "I thank our collaborators, Dorit and Yann,",
        "start": 661.53,
        "duration": 2.63
    },
    {
        "text": "for working on the alcohol disorder,",
        "start": 664.16,
        "duration": 2.182
    },
    {
        "text": "alcohol use disorder with us,",
        "start": 666.342,
        "duration": 2.118
    },
    {
        "text": "well, then mice, Qiwen Fan and Karen Luo for the help",
        "start": 668.46,
        "duration": 2.67
    },
    {
        "text": "with our brain tumor xenografts.",
        "start": 671.13,
        "duration": 3.65
    },
    {
        "text": "And I thank ACS and C&EN again",
        "start": 674.78,
        "duration": 2.827
    },
    {
        "text": "for having this wonderful event, seven years in a row",
        "start": 677.607,
        "duration": 3.653
    },
    {
        "text": "to support young scientists from such a diverse background.",
        "start": 681.26,
        "duration": 4.034
    },
    {
        "text": "And I wanna thank these agencies for their funding.",
        "start": 685.294,
        "duration": 3.109
    },
    {
        "text": "Please do reach out and let's talk about chemistry,",
        "start": 689.75,
        "duration": 2.87
    },
    {
        "text": "about life, or both, anything else.",
        "start": 692.62,
        "duration": 2.23
    },
    {
        "text": "With that, I just wanna thank you all for listening,",
        "start": 694.85,
        "duration": 2.124
    },
    {
        "text": "and I'll be taking questions from here.",
        "start": 696.974,
        "duration": 1.919
    },
    {
        "text": "Thank you so much the Ziyang.",
        "start": 699.79,
        "duration": 2.51
    },
    {
        "text": "I was wondering,",
        "start": 702.3,
        "duration": 0.833
    },
    {
        "text": "are there plans to move this combination therapy forward",
        "start": 703.133,
        "duration": 4.127
    },
    {
        "text": "into more advanced trials or anything like that?",
        "start": 707.26,
        "duration": 2.543
    },
    {
        "text": "Yes, definitely.",
        "start": 710.81,
        "duration": 0.986
    },
    {
        "text": "We are working on that.",
        "start": 711.796,
        "duration": 1.934
    },
    {
        "text": "I didn't tell you about the alcohol use disorder project,",
        "start": 713.73,
        "duration": 3.91
    },
    {
        "text": "but essentially the same approach,",
        "start": 717.64,
        "duration": 1.83
    },
    {
        "text": "we can use this mTOR inhibitor",
        "start": 719.47,
        "duration": 4.3
    },
    {
        "text": "to help patients with alcohol use disorders",
        "start": 723.77,
        "duration": 3.29
    },
    {
        "text": "and we're moving forward to see if we can use it",
        "start": 727.06,
        "duration": 5.0
    },
    {
        "text": "in a more clinically relevant setting.",
        "start": 732.06,
        "duration": 1.903
    },
    {
        "text": "Thank you so much.",
        "start": 734.81,
        "duration": 1.181
    },
    {
        "text": "(soft music)",
        "start": 735.991,
        "duration": 2.417
    }
]